Investing.com -- Tandem Diabetes Care (NASDAQ: TNDM) stock fell 5% Wednesday morning after Citi downgraded the medical device maker to Sell from Neutral, citing intensifying competitive pressures.

Morgan Stanley said second-quarter global PC shipments came in stronger than expected but warned that growth is likely to ...

Investing.com -- J.P. Morgan has upgraded Genuit Group (LON: GENG) to “overweight” from “neutral” and increased its price target to 490p from 450p, updating its valuation to December 2026. The upgrade ...

UBS has adjusted its forecast for the pound sterling, setting a new end-Q3 target of 0.8700 for the EUR/GBP exchange rate ...

UBS has revised its 2025 year-end EUR/SEK forecast to 10.75 from the previous 10.50, while maintaining its 2026 year-end forecast at 10.60. For the third quarter, UBS targets EUR/SEK at 10.90, with a ...

Investing.com - UBS has revised its Swiss franc forecast after the Swiss National Bank (SNB) showed less intervention in ...

Q3 target to 140.00 from its previous forecast of 135.00, while maintaining its year-end target at 130.00. The financial services f ...

Investing.com -- Enphase Energy (NASDAQ: ENPH) stock fell 4% after Goldman Sachs (NYSE: GS) analyst Brian Lee downgraded the ...

Investing.com -- Illumina (NASDAQ: ILMN) stock declined 3.8% Wednesday after Citi downgraded the genomic sequencing company to Sell from Neutral, citing concerns about its second-half outlook.

Jefferies has downgraded Aberdeen (LON: ABDN) to “hold” from “buy,” citing higher operational costs and limited near-term upside following a strong rally ...

Under the EU Stockpiling and Medical (TASE: BLWV) Countermeasures Strategies, officials will create a priority list of medical equipment to be stored across Europe, including vaccines, therapeutics, ...

Morgan Stanley reaffirmed its Overweight rating and “Top Pick” status on SAP in a note Wednesday, citing reassuring near-term ...